CD7 and cancer: An important issue in the use of anti-CD7 CAR-T cells against T-cell malignancies is the concept of “fratricide”, meaning the killing of therapeutic CAR-T cells by the CAR-T cells themselves due to shared expression of CD7 (Figure 1) (31).